Email This Article

Can Derivatives Cure Drug Stocks?
By Howard Simons
12/21/04 - 01:00 PM EST
It's time for pharmaceutical companies to securitize options embedded in product pipelines.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,309.92 1,091.49 2,138.44 32.12
Oil *
77.12
DOWN
154.48
DOWN
19.14
DOWN
37.61
DOWN
0.67
10 Yr
3.21%
SPDR Gold
115.06
-1.48%
-1.72%
-1.73%
-2.04%
Data delayed 20 minutes

Brokerage Partners